|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
1,770,000,000 |
Market
Cap: |
285.39(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$132.51 - $182.1 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 560 |
Guru Rank Value : 3 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
80,031 |
461,916 |
540,416 |
831,596 |
Total Sell Value |
$14,256,265 |
$81,646,316 |
$93,320,391 |
$138,453,569 |
Total People Sold |
2 |
9 |
9 |
12 |
Total Sell Transactions |
2 |
11 |
13 |
29 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Richmond Timothy J. |
SVP, Human Resources |
|
2015-02-28 |
4 |
D |
$60.50 |
$277,816 |
D/D |
(4,592) |
119,268 |
|
- |
|
Hurwich Thomas A. |
VP, Controller |
|
2015-02-28 |
4 |
D |
$60.50 |
$112,651 |
D/D |
(1,862) |
68,460 |
|
- |
|
Alban Carlos |
EVP, Commercial Operations |
|
2015-02-28 |
4 |
D |
$60.50 |
$435,600 |
D/D |
(7,200) |
236,812 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2015-02-27 |
4 |
D |
$60.52 |
$2,649,808 |
D/D |
(43,784) |
506,972 |
|
- |
|
Chase William J |
EVP, Chief Financial Officer |
|
2015-02-27 |
4 |
D |
$60.52 |
$623,295 |
D/D |
(10,299) |
226,220 |
|
- |
|
Saleki-Gerhardt Azita |
SVP, Operations |
|
2015-02-27 |
4 |
S |
$60.47 |
$127,706 |
D/D |
(2,112) |
104,555 |
|
- |
|
Saleki-Gerhardt Azita |
SVP, Operations |
|
2015-02-27 |
4 |
D |
$60.52 |
$357,129 |
D/D |
(5,901) |
106,667 |
|
- |
|
Schumacher Laura J |
EVP, Bus.Dev.,Ext.Aff.&GC |
|
2015-02-27 |
4 |
D |
$60.52 |
$1,064,184 |
D/D |
(17,584) |
307,433 |
|
- |
|
Richmond Timothy J. |
SVP, Human Resources |
|
2015-02-27 |
4 |
S |
$60.51 |
$125,492 |
D/D |
(2,074) |
123,860 |
|
- |
|
Richmond Timothy J. |
SVP, Human Resources |
|
2015-02-27 |
4 |
D |
$60.52 |
$370,867 |
D/D |
(6,128) |
125,934 |
|
- |
|
Hurwich Thomas A. |
VP, Controller |
|
2015-02-27 |
4 |
S |
$60.57 |
$71,777 |
D/D |
(1,185) |
70,322 |
|
- |
|
Hurwich Thomas A. |
VP, Controller |
|
2015-02-27 |
4 |
D |
$60.52 |
$152,752 |
D/D |
(2,524) |
71,507 |
|
- |
|
Alban Carlos |
EVP, Commercial Operations |
|
2015-02-27 |
4 |
D |
$60.52 |
$768,967 |
D/D |
(12,706) |
244,012 |
|
- |
|
Schumacher Laura J |
EVP, Bus.Dev.,Ext.Aff.&GC |
|
2015-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
52,220 |
325,017 |
|
- |
|
Richmond Timothy J. |
SVP, Human Resources |
|
2015-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
25,470 |
132,062 |
|
- |
|
Alban Carlos |
EVP, Commercial Operations |
|
2015-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
51,580 |
256,718 |
|
- |
|
Severino Michael |
EVP, R&D and CSO |
|
2015-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
52,860 |
194,485 |
|
- |
|
Hurwich Thomas A. |
VP, Controller |
|
2015-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,820 |
74,031 |
|
- |
|
Saleki-Gerhardt Azita |
SVP, Operations |
|
2015-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
26,740 |
112,568 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2015-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
165,590 |
551,918 |
|
- |
|
Chase William J |
EVP, Chief Financial Officer |
|
2015-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
56,040 |
236,519 |
|
- |
|
Richmond Timothy J. |
SVP, Human Resources |
|
2015-02-17 |
4 |
S |
$58.70 |
$14,147 |
D/D |
(241) |
106,592 |
|
- |
|
Richmond Timothy J. |
SVP, Human Resources |
|
2015-02-17 |
4 |
D |
$58.05 |
$31,986 |
D/D |
(551) |
106,833 |
|
- |
|
Saleki-Gerhardt Azita |
SVP, Operations |
|
2015-02-09 |
4 |
D |
$56.90 |
$81,083 |
I/I |
(1,425) |
1,743 |
|
- |
|
Saleki-Gerhardt Azita |
SVP, Operations |
|
2015-02-09 |
4 |
OE |
$24.07 |
$54,164 |
I/I |
2,250 |
3,168 |
|
- |
|
641 Records found
|
|
Page 25 of 26 |
|
|